A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.
about
Oral Mucositis Induced By Anticancer TherapiesOral complications in hematopoietic stem cell recipients: the role of inflammationEffect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing OutcomesSecond solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioningConditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patientsStem cell transplantation during cancer.Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single centerAllogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.
P2860
Q26777493-795BC800-F8B3-4865-8497-A094DEFE2BDFQ27027650-441A5C0D-E280-4804-899D-2EBA1B5FC08BQ30408294-799FE905-36CF-4ED8-847E-7C171CB9DCFCQ33870341-2378D938-9B48-4901-BF96-3439E24FB9F7Q34325244-E0028A70-438E-4FC1-AE31-E96E7BFA9F1EQ35647641-32E14431-2C25-4D84-B6E3-375125D2CCB7Q35797175-8D69B2B1-760B-401C-ACD5-F259398D10A3Q39095853-B48CB238-528D-4ADE-BC5F-AEC932097F1AQ39677427-C3155860-7181-4307-8CDA-B206B92B7750Q40829969-1E1802E7-002B-4AA5-9331-A2514CA3DBD9Q41106225-E1077748-A6E4-47FC-B121-E91B36D45539Q55515367-99557056-F424-47C7-BD37-F26E9AE30A06
P2860
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A prospective randomized toxic ...... tic stem cell transplantation.
@en
A prospective randomized toxic ...... tic stem cell transplantation.
@nl
type
label
A prospective randomized toxic ...... tic stem cell transplantation.
@en
A prospective randomized toxic ...... tic stem cell transplantation.
@nl
prefLabel
A prospective randomized toxic ...... tic stem cell transplantation.
@en
A prospective randomized toxic ...... tic stem cell transplantation.
@nl
P2093
P2860
P356
P1476
A prospective randomized toxic ...... tic stem cell transplantation.
@en
P2093
H Hägglund
K Garming-Legert
K Le Blanc
M Remberger
P Svenberg
P2860
P304
P356
10.1111/JOIM.12056
P407
P577
2013-03-25T00:00:00Z